Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray

Oyster Point Pharma — a small Princeton, NJ-based biotech looking to disrupt a massive eye drug market largely monopolized by two therapies — has positive pivotal trial data as it marches on a path towards US approval.